Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients.
Kyr M, Mudry P, Polaskova K, Dubska LZ, Demlova R, Kubatova J, Hlavackova E, Pilatova KC, Mazanek P, Vejmelkova K, Dusek V, Tinka P, Balaz M, Merta T, Kuttnerova Z, Turekova T, Pavelka Z, Pokorna P, Palova H, Mlnarikova M, Jezova M, Kellnerova R, Kozakova S, Slaby O, Valik D, Sterba J.
Kyr M, et al. Among authors: dubska lz.
Int J Cancer. 2024 Oct 15;155(8):1443-1454. doi: 10.1002/ijc.35062. Epub 2024 Jul 3.
Int J Cancer. 2024.
PMID: 38958237